Tafenoquine for the treatment of Plasmodium vivax malaria
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2058394
Abstract: ABSTRACT Introduction Plasmodium vivax malaria causes significant disease burden worldwide, especially in Latin America, Southeast Asia, and Oceania. P. vivax is characterized by the production of liver hypnozoites that cause clinical relapses upon periodic activation.… read more here.
Keywords: vivax malaria; vivax; plasmodium vivax; tafenoquine treatment ... See more keywords